S.A. Mason’s Gilead Sciences GILD Stock Holding History

S.A. Mason’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-525	Closed	-$58.2K	–	294
2025 Q2	$58.2K	Hold	525	–	–	0.03%	282
2025 Q1	$58.8K	Hold	525	–	–	0.03%	265
2024 Q4	$48.5K	Hold	525	–	–	0.03%	273
2024 Q3	$44K	Hold	525	–	–	0.02%	273
2024 Q2	$36K	Hold	525	–	–	0.02%	269
2024 Q1	$38.5K	Hold	525	–	–	0.02%	262
2023 Q4	$42.5K	Hold	525	–	–	0.03%	249
2023 Q3	$39.3K	Sell	525 -179	-25%	-$13.8K	0.03%	256
2023 Q2	$58.4K	Hold	704	–	–	0.04%	241
2023 Q1	$58.4K	Sell	704 -50	-7%	-$4.14K	0.04%	241
2022 Q4	$64.7K	Hold	754	–	–	0.05%	232
2022 Q3	$47K	Sell	754 -150	-17%	-$9.46K	0.04%	250
2022 Q2	$56K	Buy	904 +79	+10%	+$4.89K	0.04%	247
2022 Q1	$49K	Buy	825 +50	+6%	+$3.2K	0.03%	266
2021 Q4	$56K	Hold	775	–	–	0.03%	256
2021 Q3	$54K	Hold	775	–	–	0.04%	252
2021 Q2	$53K	Hold	775	–	–	0.04%	247
2021 Q1	$50K	Hold	775	–	–	0.04%	243
2020 Q4	$45K	Hold	775	–	–	0.04%	233
2020 Q3	$49K	Hold	775	–	–	0.05%	214
2020 Q2	$60K	Sell	775 -150	-16%	-$11.5K	0.06%	205
2020 Q1	$69K	Hold	925	–	–	0.08%	181
2019 Q4	$60K	Buy	+925	New	+$60.2K	0.06%	216

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

S.A. Mason's GILD Position: Q3 2025 in Review

S.A. Mason sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 525 shares — an estimated $58.2K sold.

S.A. Mason first reported a position in GILD in Q4 2019 and held it in 23 quarters. The position peaked at $69K in Q1 2020. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

S.A. Mason reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
S.A. Mason sold 525 Gilead Sciences shares in Q3 2025, an estimated $58.2K.
S.A. Mason first reported a position in Gilead Sciences in Q4 2019 and held it in 23 quarters.
S.A. Mason's Gilead Sciences position peaked at $69K in Q1 2020.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on S.A. Mason's 13F filing for Q3 2025, filed 14 Oct 2025.